Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Keratoconjunctivitis SiccaSjogren's SyndromeLupus Erythematosus, SystemicArthritis, RheumatoidScleroderma, Systemic
Interventions
DRUG

Ophthalmic Emulsion

Trial Locations (17)

11201

Dr. Freedman's Office, Brooklyn

11790

Dr. Wittpen's Office, Stony Brook

12159

Cornea Consultants of Albany, Albany

30322

Emory University, Atlanta

33629

Brandon Eye Clinic, Tampa

44195

The Cole Eye Institute, Cleveland

46202

Indiana University, Indianapolis

48604

Great Lakes Eye Institute, Saginaw

60612

UIC Eye Center, Chicago

66211

Hunkleler Eye Center, Overland Park

77030

Baylor College of Medicine, Houston

79903

Corona Research, El Paso

90095

UCLA, Los Angeles

92037

Eyecare of La Jolla, La Jolla

97223

Northwest Cornea, Portland

06708

Opticare, Waterbury

01453

D'Ambrosio Eye Care, Leominster

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00025818 - Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome | Biotech Hunter | Biotech Hunter